Rothschild Investment Corp IL raised its stake in shares of Danaher Co. (NYSE:DHR) by 3.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,207 shares of the conglomerate’s stock after buying an additional 700 shares during the quarter. Rothschild Investment Corp IL’s holdings in Danaher were worth $1,783,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in DHR. GQG Partners LLC purchased a new position in Danaher during the second quarter valued at $101,000. Zions Bancorporation raised its stake in Danaher by 118.3% during the third quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock valued at $106,000 after buying an additional 667 shares during the last quarter. Patten Group Inc. raised its stake in Danaher by 262.3% during the third quarter. Patten Group Inc. now owns 4,830 shares of the conglomerate’s stock valued at $114,000 after buying an additional 3,497 shares during the last quarter. Monetary Management Group Inc. raised its stake in Danaher by 10.7% during the second quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock valued at $131,000 after buying an additional 150 shares during the last quarter. Finally, Acrospire Investment Management LLC raised its stake in Danaher by 185.5% during the second quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock valued at $143,000 after buying an additional 1,100 shares during the last quarter. Institutional investors and hedge funds own 76.12% of the company’s stock.

Shares of Danaher Co. (NYSE DHR) traded down $0.59 on Tuesday, hitting $99.97. The company had a trading volume of 2,163,100 shares, compared to its average volume of 2,412,800. The company has a quick ratio of 1.00, a current ratio of 1.43 and a debt-to-equity ratio of 0.42. Danaher Co. has a one year low of $78.97 and a one year high of $100.88. The company has a market capitalization of $69,540.00, a price-to-earnings ratio of 29.75, a P/E/G ratio of 2.18 and a beta of 1.03.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be issued a $0.14 dividend. This represents a $0.56 annualized dividend and a dividend yield of 0.56%. The ex-dividend date is Thursday, December 28th. Danaher’s payout ratio is currently 16.67%.

In related news, SVP Daniel Raskas sold 37,870 shares of Danaher stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $93.33, for a total value of $3,534,407.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of Danaher stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $92.64, for a total value of $11,671,620.96. Following the completion of the sale, the chief executive officer now directly owns 271,737 shares of the company’s stock, valued at approximately $25,173,715.68. The disclosure for this sale can be found here. Insiders own 12.20% of the company’s stock.

Several research firms have recently weighed in on DHR. UBS Group began coverage on Danaher in a research note on Monday. They issued a “buy” rating and a $99.97 price target for the company. Stifel Nicolaus restated a “buy” rating and issued a $110.00 price target on shares of Danaher in a research note on Friday. Robert W. Baird restated a “buy” rating on shares of Danaher in a research note on Friday, January 12th. Royal Bank of Canada restated a “hold” rating and issued a $96.00 price target on shares of Danaher in a research note on Thursday, January 4th. Finally, Evercore ISI began coverage on Danaher in a research note on Wednesday, January 3rd. They issued an “outperform” rating for the company. One research analyst has rated the stock with a sell rating, six have given a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $96.10.

ILLEGAL ACTIVITY NOTICE: “Rothschild Investment Corp IL Buys 700 Shares of Danaher Co. (DHR)” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://www.thecerbatgem.com/2018/01/23/rothschild-investment-corp-il-buys-700-shares-of-danaher-co-dhr.html.

Danaher Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.